{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:26:36Z","timestamp":1787858796798,"version":"build-2784847793"},"reference-count":32,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.5582\/bst.2026.01043","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:08:56Z","timestamp":1774476536000},"page":"235-244","source":"Crossref","is-referenced-by-count":2,"title":["Modeling of the hepatitis B virus life cycle and the efficacy of antivirals in human iPSC-derived hepatic organoids"],"prefix":"10.5582","volume":"20","author":[{"given":"Tanbin","family":"Liu","sequence":"first","affiliation":[{"name":"The Third People&apos;s Hospital of Shenzhen and the Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Chen","sequence":"additional","affiliation":[{"name":"Central Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[{"name":"The Third People&apos;s Hospital of Shenzhen and the Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ke","sequence":"additional","affiliation":[{"name":"Central Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasen","family":"Xu","sequence":"additional","affiliation":[{"name":"The Third People&apos;s Hospital of Shenzhen and the Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[{"name":"The Third People&apos;s Hospital of Shenzhen and the Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfang","family":"Wu","sequence":"additional","affiliation":[{"name":"The Third People&apos;s Hospital of Shenzhen and the Second Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China."},{"name":"Central Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. World Health O. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine. 2019; 37:223-225.","DOI":"10.1016\/j.vaccine.2017.07.046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dandri M, Lutgehetmann M, Petersen J. Experimental models and therapeutic approaches for HBV. Semin Immunopathol. 2013; 35:7-21.","DOI":"10.1007\/s00281-012-0335-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Burwitz BJ, Zhou Z, Li W. Animal models for the study of human hepatitis B and D virus infection: New insights and progress. Antiviral Res. 2020; 182:104898.","DOI":"10.1016\/j.antiviral.2020.104898"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yuan L, Jiang J, Liu X, <i>et al<\/i>. HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation. Gut. 2019; 68:2044-2056.","DOI":"10.1136\/gutjnl-2018-316091"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Andrews MG, Kriegstein AR. Challenges of Organoid Research. Annu Rev Neurosci. 2022; 45:23-39.","DOI":"10.1146\/annurev-neuro-111020-090812"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hendriks D, Brouwers JF, Hamer K, Geurts MH, Luciana L, Massalini S, Lopez-Iglesias C, Peters PJ, Rodriguez-Colman MJ, Chuva de Sousa Lopes S, Artegiani B, Clevers H. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nat Biotechnol. 2023; 41:1567-1581.","DOI":"10.1038\/s41587-023-01680-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rumsey JW, Lorance C, Jackson M, <i>et al<\/i>. Classical Complement Pathway Inhibition in a &quot;Human-On-A-Chip&quot; Model of Autoimmune Demyelinating Neuropathies. Adv Ther (Weinh). 2022; 5.","DOI":"10.1002\/adtp.202200030"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sharma S, Rawal P, Kaur S, Puria R. Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review. Exp Cell Res. 2023; 428:113618.","DOI":"10.1016\/j.yexcr.2023.113618"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rao S, Hossain T, Mahmoudi T. 3D human liver organoids: An <i>in vitro<\/i> platform to investigate HBV infection, replication and liver tumorigenesis. Cancer Lett. 2021; 506:35-44.","DOI":"10.1016\/j.canlet.2021.02.024"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. De Crignis E, Hossain T, Romal S, <i>et al<\/i>. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma. Elife. 2021; 10.","DOI":"10.7554\/eLife.60747"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nie YZ, Zheng YW, Miyakawa K, Murata S, Zhang RR, Sekine K, Ueno Y, Takebe T, Wakita T, Ryo A, Taniguchi H. Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells. EBioMedicine. 2018; 35:114-123.","DOI":"10.1016\/j.ebiom.2018.08.014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wu F, Wu D, Ren Y, Huang Y, Feng B, Zhao N, Zhang T, Chen X, Chen S, Xu A. Generation of hepatobiliary organoids from human induced pluripotent stem cells. J Hepatol. 2019; 70:1145-1158.","DOI":"10.1016\/j.jhep.2018.12.028"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shi Y, Deng J, Sang X, Wang Y, He F, Chen X, Xu A, Wu F. Generation of Hepatocytes and Nonparenchymal Cell Codifferentiation System from Human-Induced Pluripotent Stem Cells. Stem Cells Int. 2022; 2022:3222427.","DOI":"10.1155\/2022\/3222427"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Xu J, Sang X, He Y, Ke J, Xu J, Liu T, Wang J, Zhai H, Chen X, Shi X, Wu F. Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids <i>via<\/i> the cAMP-PKA pathway. Front Pharmacol. 2025; 16:1730255.","DOI":"10.3389\/fphar.2025.1730255"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother. 1997; 41:1715-1720.","DOI":"10.1128\/AAC.41.8.1715"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yan H, Zhong G, Xu G, <i>et al<\/i>. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012; 1:e00049.","DOI":"10.7554\/eLife.00049"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wu D, Chen X, Sheng Q, Chen W, Zhang Y, Wu F. Production of Functional Hepatobiliary Organoids from Human Pluripotent Stem Cells. Int J Stem Cells. 2021; 14:119-126.","DOI":"10.15283\/ijsc20152"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science. 2001; 294:559-563.","DOI":"10.1126\/science.1063889"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Stanger BZ. Notch signaling controls liver development by regulating biliary differentiation. Development. 2009; 136:1727-1739.","DOI":"10.1242\/dev.029140"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Godoy P, Hewitt NJ, Albrecht U, <i>et al<\/i>. Recent advances in 2D and 3D <i>in vitro<\/i> systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013; 87:1315-1530.","DOI":"10.1007\/s00204-013-1078-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Prior N, Inacio P, Huch M. Liver organoids: from basic research to therapeutic applications. Gut. 2019; 68:2228-2237.","DOI":"10.1136\/gutjnl-2019-319256"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Youn DY, Xiaoli AM, Zong H, Okada J, Liu L, Pessin J, Pessin JE, Yang F. The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc). Mol Metab. 2021; 48:101227.","DOI":"10.1016\/j.molmet.2021.101227"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bell CC, Lauschke VM, Vorrink SU, Palmgren H, Duffin R, Andersson TB, Ingelman-Sundberg M. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive <i>In Vitro<\/i> Systems for Drug-Induced Liver Injury. Drug Metab Dispos. 2017; 45:419-429.","DOI":"10.1124\/dmd.116.074369"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016; 64:S4-S16.","DOI":"10.1016\/j.jhep.2016.01.027"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, Petrachenkova M, Lehr T, Lempp FA, Wedemeyer H, Haag M, Schwab M, Haefeli WE, Blank A, Urban S. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib\/IIa study. J Hepatol. 2016; 65:490-498.","DOI":"10.1016\/j.jhep.2016.04.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386:1546-1555.","DOI":"10.1016\/S0140-6736(15)61412-X"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Verrier ER, Colpitts CC, Schuster C, Zeisel MB, Baumert TF. Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection. Viruses. 2016; 8.","DOI":"10.3390\/v8090261"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ortega-Prieto AM, Dorner M. Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection. Vaccines (Basel). 2017; 5.","DOI":"10.3390\/vaccines5030024"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Liu Y, Maya S, Ploss A. Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Viruses. 2021; 13.","DOI":"10.3390\/v13050777"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Torresi J, Tran BM, Christiansen D, Earnest-Silveira L, Schwab RHM, Vincan E. HBV-related hepatocarcinogenesis: The role of signalling pathways and innovative <i>ex vivo<\/i> research models. BMC Cancer. 2019; 19:707.","DOI":"10.1186\/s12885-019-5916-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Watashi K, Sluder A, Daito T, <i>et al<\/i>. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology. 2014; 59:1726-1737.","DOI":"10.1002\/hep.26982"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Park JH, Iwamoto M, Yun JH, <i>et al<\/i>. Structural insights into the HBV receptor and bile acid transporter NTCP. Nature. 2022; 606:1027-1031.","DOI":"10.1038\/s41586-022-04857-0"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/2\/20_2026.01043\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T03:27:29Z","timestamp":1779506849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/2\/20_2026.01043\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2026.01043","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"2026.01043"}}